Related Experiment Video
Updated: Feb 21, 2026

Author Spotlight: Time and Cost-Effective Fibrinogen-PAGE for Fibrinogenolytic Studies
Published on: April 19, 2024
Fibrinolytic activity in Nigerian diabetics with renal insufficiency
E I Unuigbe1, A A Famodu, C E Umunna
1Department of Medicine, University of Benin Teaching Hospital, Benin City, Nigeria. evelynunuigbe@hotmail.com
Abstract:
Diabetics have reduced fibrinolytic activity while chronic renal failure patients are prone to both haemorrhagic diathesis and reduced fibrinolysis. In the quest to find out what obtains when diabetics develop renal impairment, fibrinolytic activity was studied in 51 known diabetics consisting of 9 diabetics with normal renal function, 13 with mild renal impairment and 29 in chronic renal failure. No patient had end-stage renal disease and none was on dialysis therapy. Plasma fibrinogen concentration (PFC) was measured using clot weight method and euglobulin lysis time (ELT) as a measure of fibrinolytic activity was also measured. Our results show that PFC and ELT did not differ significantly in the different groups of diabetics. There was also no correlation between the serum creatinine of all diabetics and PFC on one hand and ELT on the other hand. We conclude that Nigerian diabetics probably still benefit from enhanced fibrinolysis before they reach end-stage renal disease.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Dipeptidyl Peptidase 4 Inhibitors

